GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Il Yang Pharmaceutical Co Ltd (XKRX:007570) » Definitions » EPS (Basic)

Il Yang Pharmaceutical Co (XKRX:007570) EPS (Basic) : ₩557.00 (TTM As of Dec. 2024)


View and export this data going back to 1974. Start your Free Trial

What is Il Yang Pharmaceutical Co EPS (Basic)?

Il Yang Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₩192.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩557.00.

Il Yang Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2024 was ₩192.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩557.00.

Il Yang Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2024 was ₩194.24. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 562.43.

During the past 3 years, the average EPS without NRI Growth Rate was -9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Il Yang Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 38.10% per year. The lowest was -38.30% per year. And the median was 22.60% per year.


Il Yang Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Il Yang Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Il Yang Pharmaceutical Co EPS (Basic) Chart

Il Yang Pharmaceutical Co Annual Data
Trend Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 597.00 771.00 1,045.00 -131.00 557.00

Il Yang Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -399.00 112.00 61.00 192.00 192.00

Il Yang Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Il Yang Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10257.274-0)/18.415
=557.01

Il Yang Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3694.477-0)/19.720
=187.35

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩557.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Il Yang Pharmaceutical Co  (XKRX:007570) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Il Yang Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Il Yang Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Il Yang Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
110, hagal-ro, Giheung-gu, Yongin-si, Seoul, Gyeonggi, KOR
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.

Il Yang Pharmaceutical Co Headlines

No Headlines